212 related articles for article (PubMed ID: 19954089)
21. Neuroleptics for behavioral symptoms of dementia.
Reynolds PL; Strayer SM
J Fam Pract; 2000 Jan; 49(1):78-9. PubMed ID: 10678345
[No Abstract] [Full Text] [Related]
22. Behavioral and psychological symptoms of dementia: a current focus for clinicians, researchers, and caregivers.
Finkel SI
J Clin Psychiatry; 2001; 62 Suppl 21():3-6. PubMed ID: 11584987
[TBL] [Abstract][Full Text] [Related]
23. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of treatment for geropsychiatric patients with severe mental illness.
Schneider LS
Psychopharmacol Bull; 1993; 29(4):501-24. PubMed ID: 8084981
[TBL] [Abstract][Full Text] [Related]
25. Issues facing home-based medical support services.
Kinoshita T; Hanabusa H
Psychogeriatrics; 2010 Jun; 10(2):90-4. PubMed ID: 20738813
[TBL] [Abstract][Full Text] [Related]
26. Behavioral and psychological symptoms of dementia. Assisting the caregiver and managing the patient.
Finkel SI
Geriatrics; 2002 Nov; 57(11):44-6. PubMed ID: 12442568
[TBL] [Abstract][Full Text] [Related]
27. Agitation. How to manage behavior disturbances in the older patient with dementia.
Neugroschl J
Geriatrics; 2002 Apr; 57(4):33-7; quiz 40. PubMed ID: 11974389
[TBL] [Abstract][Full Text] [Related]
28. The Treatment of Behavioral and Psychological Symptoms of Dementia: Weighing Benefits and Risks.
Zdanys KF; Carvalho AF; Tampi RR; Steffens DC
Curr Alzheimer Res; 2016; 13(10):1124-33. PubMed ID: 27160166
[TBL] [Abstract][Full Text] [Related]
29. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
[TBL] [Abstract][Full Text] [Related]
30. ["Judicious" use of neuroleptic drugs in the treatment of behavioral symptoms in the course of Alzheimer disease].
Riva E; Nobili A; Trecate F
Recenti Prog Med; 1998 Nov; 89(11):598-603. PubMed ID: 9844448
[TBL] [Abstract][Full Text] [Related]
31. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors.
Sankaranarayanan J; Puumala SE
Clin Ther; 2007 Apr; 29(4):723-41. PubMed ID: 17617297
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological treatment of behavioural and psychological symptoms of dementia in psychogeriatric inpatient units.
Restifo S; Lemon V; Waters F
Australas Psychiatry; 2011 Feb; 19(1):59-63. PubMed ID: 21189108
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological treatment of the psychosis of Alzheimer's disease: what is the best approach?
Madhusoodanan S; Shah P; Brenner R; Gupta S
CNS Drugs; 2007; 21(2):101-15. PubMed ID: 17284093
[TBL] [Abstract][Full Text] [Related]
34. The elderly safety imperative and antipsychotic usage.
Chahine LM; Acar D; Chemali Z
Harv Rev Psychiatry; 2010; 18(3):158-72. PubMed ID: 20415632
[TBL] [Abstract][Full Text] [Related]
35. Steps to managing difficult behavior in people with dementia.
Han LF; Davidson HE; Gravenstein S
Med Health R I; 2009 May; 92(5):182-4. PubMed ID: 19530485
[No Abstract] [Full Text] [Related]
36. Indications of atypical antipsychotics in the elderly.
McKean A; Monasterio E
Expert Rev Clin Pharmacol; 2015 Jan; 8(1):5-7. PubMed ID: 25354148
[TBL] [Abstract][Full Text] [Related]
37. The role of norepinephrine in the behavioral and psychological symptoms of dementia.
Herrmann N; Lanctôt KL; Khan LR
J Neuropsychiatry Clin Neurosci; 2004; 16(3):261-76. PubMed ID: 15377733
[TBL] [Abstract][Full Text] [Related]
38. Audit of antipsychotic prescribing in dementia: Cambridgeshire results and lessons learnt.
Wightman R; Fielding J; Green S
Psychiatr Danub; 2011 Sep; 23 Suppl 1():S126-9. PubMed ID: 21894119
[TBL] [Abstract][Full Text] [Related]
39. Assessing antipsychotic effectiveness in dementia: a factor analysis approach.
Espinoza R
J Am Med Dir Assoc; 2003; 4(2):113-4. PubMed ID: 12807586
[No Abstract] [Full Text] [Related]
40. [Atypical antipsychotics for elderly patients: to prescribe or to ban?].
Rollini M; Schulz P
Rev Med Suisse; 2008 Apr; 4(153):979-80, 982-4. PubMed ID: 18549086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
